Note 13 - Subsequent Events (Details Textual) - Changzhou Eminence Biotechnology [Member] - Subsequent Event [Member] $ in Millions |
Oct. 20, 2020
USD ($)
|
---|---|
Business Acquisition, Percentage of Voting Interests Acquired | 47.60% |
Business Combination, Consideration Transferred, Total | $ 10 |
X | ||||||||||
- Definition Percentage of voting equity interests acquired at the acquisition date in the business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|